Tag: National Policy Analysis #496
Fighting Disease is Better Than Suing Over It
The FDA may have severely undermined a group of personal injury attorneys looking to sue the makers of a new class of wonder drugs for schizophrenia. It turns out that the nation's premier drug regulatory agency recently agreed with the ...